By Drug Target Review2024-09-03T12:00:07
The findings could aid the design of more stable drugs and improve the understanding of diseases linked to peptide aggregation.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2026-03-26T13:58:00Z
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-04-12T15:28:08
Sponsored by nanoComposix
2024-01-19T07:40:55
Sponsored by Euretos
Site powered by Webvision Cloud